IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.274
-0.010 (-3.66%)
At close: Apr 28, 2026, 4:00 PM EDT
0.285
+0.011 (4.13%)
After-hours: Apr 28, 2026, 7:47 PM EDT
IceCure Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 3.38 | 3.29 | 3.23 | 3.09 | 4.14 | |
| Revenue Growth (YoY) | 2.67% | 1.92% | 4.67% | -25.45% | 6.98% | |
| Cost of Revenue | 2.15 | 1.84 | 1.93 | 1.64 | 1.94 | |
| Gross Profit | 1.23 | 1.45 | 1.3 | 1.45 | 2.2 | |
| Selling, General & Admin | 8.89 | 10.05 | 8.6 | 9.06 | 6.04 | |
| Research & Development | 7.43 | 7.1 | 8.27 | 9.12 | 5.88 | |
| Operating Expenses | 16.32 | 17.15 | 16.88 | 18.18 | 11.92 | |
| Operating Income | -15.09 | -15.7 | -15.58 | -16.74 | -9.72 | |
| Interest Expense | - | - | - | -0.24 | -0.17 | |
| Interest & Investment Income | 0.04 | 0.38 | 0.92 | - | - | |
| Pretax Income | -15.06 | -15.32 | -14.65 | -16.98 | -9.9 | |
| Net Income | -15.06 | -15.32 | -14.65 | -16.98 | -9.9 | |
| Net Income to Common | -15.06 | -15.32 | -14.65 | -16.98 | -9.9 | |
| Shares Outstanding (Basic) | 64 | 51 | 46 | 37 | 29 | |
| Shares Outstanding (Diluted) | 64 | 51 | 46 | 37 | 29 | |
| Shares Change (YoY) | 24.97% | 11.48% | 23.29% | 29.66% | 66.67% | |
| EPS (Basic) | -0.24 | -0.30 | -0.32 | -0.46 | -0.35 | |
| EPS (Diluted) | -0.24 | -0.30 | -0.32 | -0.46 | -0.35 | |
| Free Cash Flow | -14.61 | -12.63 | -13.03 | -15.18 | -13.14 | |
| Free Cash Flow Per Share | -0.23 | -0.25 | -0.29 | -0.41 | -0.46 | |
| Gross Margin | 36.28% | 44.09% | 40.26% | 46.84% | 53.04% | |
| Operating Margin | -446.70% | -476.94% | -482.38% | -542.59% | -234.99% | |
| Profit Margin | -445.61% | -465.45% | -453.76% | -550.34% | -239.13% | |
| Free Cash Flow Margin | -432.38% | -383.89% | -403.53% | -492.16% | -317.50% | |
| EBITDA | -14.8 | -15.36 | -15.25 | -16.49 | -9.6 | |
| EBITDA Margin | - | - | - | - | -231.92% | |
| D&A For EBITDA | 0.3 | 0.33 | 0.32 | 0.25 | 0.13 | |
| EBIT | -15.09 | -15.7 | -15.58 | -16.74 | -9.72 | |
| EBIT Margin | - | - | - | - | -234.99% | |
| Advertising Expenses | 0.12 | 0.03 | 0.09 | 0.07 | 0.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.